Sunshine Biopharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
1.70
-
-
447.20
Cost of Goods Sold (COGS) incl. D&A
-
-
-
60.70
6.60
393.50
Gross Income
-
-
-
60.70
6.60
53.70
SG&A Expense
1,936.10
1,755.10
777.70
932.40
850.60
1,220.20
EBIT
1,936.10
1,755.10
780.30
993.10
857.20
1,166.50
Unusual Expense
549.00
-
565.60
2,468.80
76.90
871.70
Non Operating Income/Expense
-
-
0.20
-
1.30
41.50
Interest Expense
6.50
179.10
307.20
34.70
104.80
159.40
Pretax Income
2,491.50
1,934.20
1,652.90
3,496.70
1,040.20
2,156.20
Consolidated Net Income
2,491.50
1,934.20
1,652.90
3,496.70
1,040.20
2,156.20
Net Income
2,491.50
1,934.20
1,652.90
3,496.70
1,040.20
2,156.20
Net Income After Extraordinaries
2,491.50
1,934.20
1,652.90
3,496.70
1,040.20
2,156.20
Net Income Available to Common
2,491.50
1,934.20
1,652.90
3,496.70
1,040.20
2,156.20
EPS (Basic)
0.04
0.03
0.01
0.01
0.00
0.04
Basic Shares Outstanding
55,395.80
66,131.70
122,278.90
424,874.50
872,685.60
60,936.20
EPS (Diluted)
0.04
0.03
0.01
0.01
0.00
0.04
Diluted Shares Outstanding
55,395.80
66,131.70
122,278.90
424,874.50
872,685.60
60,936.20
EBITDA
1,936.10
1,755.10
776.00
932.40
850.60
1,117.20
About Sunshine Biopharma
View Profile
